Dianthus Therapeutics (DNTH) Enterprise Value Growth (3y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -74.84% |
| Sep 30, 2025 | -55.96% |
| Jun 30, 2025 | -22.47% |
| Mar 31, 2025 | -18.90% |
| Dec 31, 2024 | -15.75% |
| Sep 30, 2024 | -13.43% |
| Jun 30, 2024 | -20.18% |
| Mar 31, 2024 | -41.78% |
| Dec 31, 2023 | -5.29% |
| Sep 30, 2023 | -5.49% |
| Jun 30, 2023 | 32.11% |
| Mar 31, 2023 | 42.35% |
| Dec 31, 2022 | 19.69% |
| Sep 30, 2022 | 12.89% |
| Jun 30, 2022 | 6.81% |
| Mar 31, 2022 | -7.15% |
| Dec 31, 2021 | -7.46% |
| Sep 30, 2021 | -6.42% |
| Jun 30, 2021 | -6.18% |
| Dec 31, 2020 | -42.38% |
| Sep 30, 2020 | -39.21% |
| Jun 30, 2020 | -40.40% |